Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
PUT
Apollo Global Management
APO
$76B
| $53.6M | 0.01% |
370,000
| – | – |
|
752
CALL
Chipotle Mexican Grill
CMG
$40.7B
| $53.4M | 0.01% |
1,442,400
+990,000
| +219% | +$35.8M |
|
753
CALL
Marvell Technology
MRVL
$187B
| $53.1M | 0.01% |
625,300
-1,527,800
| -71% | -$134M |
|
754
Rollins
ROL
$17.9B
| $52.7M | 0.01% |
877,958
+156,239
| +22% | +$9.18M |
|
755
VanEck Semiconductor ETF
SMH
$70.1B
| $52.7M | 0.01% |
146,312
+81,100
| +124% | +$28.5M |
|
756
Tyson Foods
TSN
$20.1B
| $52.4M | 0.01% |
893,793
+82,337
| +10% | +$4.52M |
|
757
GoDaddy
GDDY
$11.6B
| $52.2M | 0.01% |
420,748
-150,428
| -26% | -$19.5M |
|
758
AerCap
AER
$23.5B
| $51.9M | 0.01% |
360,921
+2,875
| +0.8% | +$381K |
|
759
Loews
L
$23.3B
| $51.8M | 0.01% |
492,218
-102,278
| -17% | -$10.6M |
|
760
Principal Financial Group
PFG
$24.4B
| $51.5M | 0.01% |
584,244
-85,612
| -13% | -$7.23M |
|
761
Everest Group
EG
$14.2B
| $51.5M | 0.01% |
151,674
-8,403
| -5% | -$2.78M |
|
762
PUT
SLB Ltd
SLB
$78.9B
| $51.4M | 0.01% |
1,338,200
| – | – |
|
763
Edison International
EIX
$26.1B
| $51.3M | 0.01% |
854,635
-516,141
| -38% | -$29.6M |
|
764
CALL
State Street SPDR S&P Retail ETF
XRT
$652M
| $51.2M | 0.01% |
+600,000
| New | +$50.4M |
|
765
Jack Henry & Associates
JKHY
$11B
| $51.1M | 0.01% |
280,071
-80,870
| -22% | -$13.5M |
|
|
NVO
766
PUT
Novo Nordisk
NVO
$209B
| $50.9M | 0.01% |
1,000,200
-1,398,900
| -58% | -$71.5M |
|
767
CALL
Booking.com
BKNG
$160B
| $50.9M | 0.01% |
237,500
| – | – |
|
768
PUT
Agnico Eagle Mines
AEM
$91.4B
| $50.9M | 0.01% |
300,000
| – | – |
|
769
PUT
Williams-Sonoma
WSM
$29.5B
| $50.6M | 0.01% |
283,100
-51,300
| -15% | -$9.61M |
|
770
CALL
MongoDB
MDB
$33.5B
| $50.5M | 0.01% |
120,400
-38,500
| -24% | -$14M |
|
771
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.9B
| $50.5M | 0.01% |
633,761
+615,000
| +3,278% | +$49.1M |
|
772
Labcorp
LH
$26.1B
| $50.5M | 0.01% |
201,343
-13,188
| -6% | -$3.5M |
|
773
Weyerhaeuser
WY
$18.2B
| $50.4M | 0.01% |
2,128,767
-132,113
| -6% | -$3.06M |
|
774
Workiva
WK
$3.66B
| $50.2M | 0.01% |
582,586
+490,351
| +532% | +$43.4M |
|
775
Intapp
INTA
$2.99B
| $50.2M | 0.01% |
1,094,989
+1,008,128
| +1,161% | +$41.8M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.